Hospital
Lima Memorial Joint Operating Company
Lima Memorial Joint Operating Company was paid $28.30M by Medicaid between Jan 2018 and Dec 2024, across 396 billing codes. Its largest line is 99283, emergency room visit (moderate) — 13% of everything it billed.
33Billing provider infoLIMA MEMORIAL JOINT OPERATING COMPANY
LIMA, OH 45804
LIMA, OH 45804
33aNPI1336144732assigned 06/14/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$28.30M
24GClaims800,558
24DCodes billed396
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#40 of 101
Median peer was paid$22.32M
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 48,115 | $1.44M | |
| 2019 | 44,116 | $1.29M | |
| 2020 | 37,940 | $1.71M | |
| 2021 | 45,126 | $2.03M | |
| 2022 | 105,297 | $4.47M | |
| 2023 | 324,316 | $11.21M | |
| 2024incomplete | 195,648 | $6.15M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 35,339 | 32,342 | $3.66M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10% | 44,166 | 35,492 | $2.90M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.4% | 21,620 | 19,104 | $2.65M |
| 96361 | Intravenous infusion, hydration; each additional hour | 6.7% | 6,708 | 5,416 | $1.90M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.4% | 30,615 | 25,457 | $1.82M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.2% | 12,550 | 10,255 | $1.48M |
| 70450 | Computed tomography, head or brain; without contrast material | 2.9% | 3,463 | 2,797 | $815K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.4% | 2,955 | 2,278 | $693K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2.1% | 3,776 | 3,136 | $593K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.9% | 7,186 | 2,127 | $527K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.6% | 6,673 | 2,245 | $443K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.6% | 7,028 | 4,741 | $439K |
384 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.5% | 2,404 | $418K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.4% | 1,519 | $387K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.3% | 11,086 | $363K |
| 93458 | 1.1% | 397 | $319K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 5,104 | $304K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.1% | 4,770 | $303K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.1% | 1,565 | $300K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.0% | 2,568 | $296K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 816 | $278K |
| G0378 | Hospital observation service, per hour | <1% | 3,854 | $266K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,377 | $260K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,252 | $258K |
| 87631 | <1% | 2,746 | $253K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 3,994 | $218K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 3,756 | $206K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 3,210 | $188K |
| 59025 | Fetal non-stress test | <1% | 1,271 | $185K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 23,047 | $180K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 796 | $178K |
| 80053 | Comprehensive metabolic panel | <1% | 20,520 | $176K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,662 | $168K |
| 81513 | <1% | 1,433 | $158K | |
| 90999 | Dialysis (unlisted procedure) | <1% | 7,161 | $156K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,341 | $142K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 538 | $135K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 2,340 | $126K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,580 | $118K |
| 96161 | <1% | 1,199 | $113K | |
| 64488 | <1% | 739 | $109K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,158 | $100K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 45,944 | $99K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 597 | $97K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 2,580 | $95K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 806 | $87K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,956 | $85K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 165 | $83K |
| 76830 | Ultrasound, transvaginal | <1% | 1,174 | $79K |
| 93017 | <1% | 1,176 | $77K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,061 | $73K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 313 | $73K |
| 71045 | Radiologic examination, chest; single view | <1% | 15,489 | $66K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,033 | $66K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,895 | $62K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,733 | $60K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 24,695 | $57K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,245 | $54K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,949 | $54K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 35 | $52K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 348 | $52K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 415 | $52K |
| 90837 | Psychotherapy session, about an hour | <1% | 439 | $49K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 1,282 | $49K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 723 | $48K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,074 | $47K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 615 | $47K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 438 | $46K |
| 80061 | Lipid panel | <1% | 4,727 | $46K |
| 93971 | <1% | 633 | $44K | |
| 76642 | <1% | 470 | $44K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 22,873 | $43K |
| 93970 | <1% | 325 | $42K | |
| 84484 | <1% | 12,032 | $42K | |
| 97161 | <1% | 974 | $41K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,930 | $40K |
| 97113 | <1% | 537 | $38K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 254 | $36K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 3,104 | $35K |
| 92557 | <1% | 583 | $33K | |
| 95811 | <1% | 46 | $32K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,517 | $32K |
| Q5105 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units | <1% | 2,144 | $30K |
| 96160 | <1% | 279 | $30K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 907 | $29K |
| C9600 | Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch | <1% | 17 | $28K |
| 84439 | <1% | 2,515 | $27K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,088 | $26K |
| 95886 | <1% | 145 | $26K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 23 | $25K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,143 | $25K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 9,373 | $25K |
| 83735 | <1% | 9,069 | $25K | |
| 97165 | <1% | 551 | $25K | |
| 76770 | <1% | 153 | $24K | |
| 87070 | <1% | 4,282 | $23K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 6,330 | $23K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 66 | $23K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 2,942 | $23K |
| 86850 | <1% | 1,301 | $22K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,926 | $22K |
| 97116 | <1% | 1,014 | $20K | |
| 81001 | <1% | 23,693 | $19K | |
| 80076 | <1% | 2,807 | $19K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 9,590 | $19K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 535 | $18K |
| 90670 | <1% | 1,032 | $18K | |
| 82607 | <1% | 1,422 | $18K | |
| 82728 | <1% | 1,483 | $17K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 5,966 | $17K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 129 | $17K |
| 74018 | <1% | 716 | $17K | |
| 93225 | <1% | 304 | $16K | |
| 86900 | <1% | 1,505 | $15K | |
| 96367 | <1% | 500 | $15K | |
| 76536 | <1% | 157 | $15K | |
| 99381 | <1% | 327 | $15K | |
| 86140 | <1% | 984 | $13K | |
| 72100 | <1% | 735 | $13K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 668 | $13K |
| 94060 | <1% | 113 | $13K | |
| 70486 | <1% | 244 | $12K | |
| 71250 | <1% | 174 | $12K | |
| 85027 | <1% | 1,998 | $11K | |
| 83540 | <1% | 1,679 | $11K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 326 | $11K |
| 92567 | <1% | 1,004 | $11K | |
| 73630 | <1% | 1,438 | $11K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 944 | $11K |
| 84466 | <1% | 1,561 | $11K | |
| 82746 | <1% | 1,248 | $10K | |
| 84702 | <1% | 1,018 | $10K | |
| 73130 | <1% | 827 | $10K | |
| 83655 | <1% | 441 | $10K | |
| 86780 | <1% | 1,196 | $10K | |
| 82570 | <1% | 1,433 | $9K | |
| 86703 | <1% | 699 | $9K | |
| 93296 | <1% | 721 | $9K | |
| 90686 | <1% | 1,174 | $9K | |
| 87340 | <1% | 872 | $9K | |
| 99385 | <1% | 249 | $9K | |
| 71271 | <1% | 66 | $9K | |
| 90648 | <1% | 1,014 | $8K | |
| J3490 | Unclassified drugs | <1% | 1,555 | $8K |
| 12001 | <1% | 53 | $8K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 176 | $8K |
| 87428 | <1% | 6,782 | $8K | |
| 73030 | <1% | 634 | $8K | |
| 10060 | <1% | 51 | $8K | |
| S9472 | Cardiac rehabilitation program, non-physician provider, per diem | <1% | 131 | $7K |
| 73610 | <1% | 842 | $7K | |
| 86803 | <1% | 744 | $7K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 87 | $7K |
| 85610 | <1% | 11,208 | $7K | |
| 83690 | <1% | 9,667 | $6K | |
| 82043 | <1% | 1,006 | $6K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 12,438 | $6K |
| 87481 | <1% | 1,454 | $6K | |
| 86038 | <1% | 258 | $6K | |
| 93925 | <1% | 59 | $6K | |
| 93880 | <1% | 98 | $5K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 365 | $5K |
| 90681 | <1% | 425 | $5K | |
| 87641 | <1% | 835 | $5K | |
| 90633 | <1% | 726 | $5K | |
| 87510 | <1% | 202 | $5K | |
| 83880 | <1% | 1,547 | $5K | |
| 90723 | <1% | 791 | $5K | |
| 87077 | <1% | 1,959 | $5K | |
| 83970 | <1% | 365 | $5K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 14 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 8,237 | $4K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,468 | $4K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 747 | $4K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,528 | $4K |
| 84153 | <1% | 346 | $4K | |
| 81025 | <1% | 9,221 | $4K | |
| 93298 | <1% | 1,026 | $4K | |
| 72040 | <1% | 121 | $4K | |
| 88142 | <1% | 1,342 | $4K | |
| 76818 | <1% | 201 | $4K | |
| 87480 | <1% | 202 | $4K | |
| 87493 | <1% | 650 | $4K | |
| 92587 | <1% | 61 | $4K | |
| 87500 | <1% | 713 | $4K | |
| 85652 | <1% | 1,101 | $4K | |
| 73110 | <1% | 310 | $4K | |
| 82565 | <1% | 1,049 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 121 | $4K |
| 86225 | <1% | 290 | $4K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,274 | $4K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 939 | $4K |
| 83605 | <1% | 2,149 | $4K | |
| 94726 | <1% | 63 | $4K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 23 | $4K |
| 96376 | <1% | 1,779 | $3K | |
| 93922 | <1% | 49 | $3K | |
| 73562 | <1% | 548 | $3K | |
| 88307 | <1% | 31 | $3K | |
| 82077 | <1% | 1,187 | $3K | |
| 87430 | <1% | 7,186 | $3K | |
| 87507 | <1% | 22 | $3K | |
| 92552 | <1% | 61 | $3K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 126 | $3K |
| 86901 | <1% | 1,505 | $3K | |
| 84156 | <1% | 881 | $3K | |
| A4657 | Syringe, with or without needle, each | <1% | 4,232 | $3K |
| 87660 | <1% | 221 | $3K | |
| 72072 | <1% | 106 | $3K | |
| 84550 | <1% | 663 | $3K | |
| 0002A | <1% | 72 | $3K | |
| 93270 | <1% | 20 | $2K | |
| 73502 | <1% | 134 | $2K | |
| 86430 | <1% | 167 | $2K | |
| 82950 | <1% | 559 | $2K | |
| 86695 | <1% | 156 | $2K | |
| 87186 | <1% | 1,881 | $2K | |
| 77065 | Tomosynthesis, mammo | <1% | 133 | $2K |
| 86696 | <1% | 156 | $2K | |
| 84703 | <1% | 654 | $2K | |
| 90716 | <1% | 295 | $2K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 99 | $2K |
| 0001A | <1% | 73 | $2K | |
| 84100 | <1% | 1,400 | $2K | |
| 87081 | <1% | 701 | $2K | |
| 83525 | <1% | 109 | $2K | |
| 80143 | <1% | 487 | $2K | |
| 95816 | <1% | 14 | $2K | |
| 85379 | <1% | 1,385 | $2K | |
| 86762 | <1% | 353 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 233 | $2K |
| 72141 | <1% | 14 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 9,473 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,725 | $2K |
| 51798 | <1% | 501 | $2K | |
| 87486 | <1% | 68 | $2K | |
| 88174 | <1% | 77 | $2K | |
| 99383 | <1% | 27 | $2K | |
| 90651 | <1% | 92 | $2K | |
| 83615 | <1% | 694 | $1K | |
| 85730 | <1% | 2,157 | $1K | |
| 31575 | <1% | 40 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,640 | $1K |
| 90715 | <1% | 133 | $1K | |
| 84145 | <1% | 337 | $1K | |
| 84450 | <1% | 223 | $1K | |
| 90707 | <1% | 297 | $1K | |
| H1000 | Prenatal care, at-risk assessment | <1% | 189 | $1K |
| 82803 | <1% | 665 | $1K | |
| 90696 | <1% | 168 | $1K | |
| 86141 | <1% | 27 | $1K | |
| 77062 | <1% | 46 | $1K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 117 | $1K |
| 00731 | <1% | 426 | $1K | |
| 99406 | <1% | 66 | $1K | |
| 82040 | <1% | 431 | $1K | |
| 87150 | <1% | 295 | $980.02 | |
| 84403 | <1% | 61 | $921.86 | |
| 85014 | <1% | 727 | $921.51 | |
| 81003 | <1% | 2,340 | $918.67 | |
| 92523 | <1% | 12 | $914.57 | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 620 | $913.16 |
| 00840 | <1% | 282 | $892.30 | |
| 82150 | <1% | 327 | $861.73 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,308 | $853.19 |
| 80179 | <1% | 446 | $852.42 | |
| 87040 | <1% | 652 | $819.13 | |
| 90677 | <1% | 59 | $814.92 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 69 | $802.60 |
| 87581 | <1% | 68 | $788.37 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 21 | $784.33 |
| 84132 | <1% | 728 | $775.95 | |
| 90700 | <1% | 212 | $769.37 | |
| 85018 | <1% | 768 | $761.55 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,995 | $740.63 |
| 84146 | <1% | 179 | $737.11 | |
| 82330 | <1% | 176 | $717.10 | |
| 82550 | <1% | 198 | $686.39 | |
| 87420 | <1% | 825 | $676.84 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,739 | $645.60 |
| 94729 | <1% | 16 | $629.57 | |
| 72131 | <1% | 14 | $595.17 | |
| 73590 | <1% | 60 | $580.56 | |
| 76801 | <1% | 72 | $563.84 | |
| 85045 | <1% | 295 | $542.94 | |
| 84481 | <1% | 29 | $524.73 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 102 | $524.00 |
| 90710 | <1% | 148 | $523.56 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 835 | $518.70 |
| 90734 | <1% | 97 | $498.62 | |
| J7999 | Compounded drug, not otherwise classified | <1% | 327 | $468.71 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 696 | $452.16 |
| 84520 | <1% | 645 | $433.33 | |
| 71101 | <1% | 18 | $408.88 | |
| 87205 | <1% | 590 | $386.88 | |
| 80074 | <1% | 26 | $385.26 | |
| 77066 | Tomosynthesis, mammo | <1% | 99 | $361.54 |
| 73090 | <1% | 63 | $360.69 | |
| J2704 | Injection, propofol, 10 mg | <1% | 4,270 | $342.99 |
| 82248 | <1% | 58 | $336.53 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 24 | $327.21 |
| 97162 | <1% | 15 | $321.06 | |
| 82310 | <1% | 431 | $312.54 | |
| 84075 | <1% | 344 | $308.64 | |
| 74022 | <1% | 96 | $306.66 | |
| 82140 | <1% | 63 | $303.01 | |
| 83001 | <1% | 16 | $298.17 | |
| 83874 | <1% | 41 | $297.72 | |
| 72170 | <1% | 58 | $293.62 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 499 | $253.56 |
| 73080 | <1% | 45 | $243.72 | |
| 99382 | <1% | 15 | $243.17 | |
| 84402 | <1% | 12 | $228.33 | |
| 88304 | <1% | 472 | $227.21 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,489 | $219.48 |
| 86308 | <1% | 47 | $215.48 | |
| 87088 | <1% | 148 | $162.64 | |
| 36416 | <1% | 3,942 | $162.00 | |
| 84460 | <1% | 85 | $159.96 | |
| 90694 | <1% | 47 | $154.46 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 764 | $152.36 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 7,837 | $141.07 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,004 | $140.32 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 256 | $128.23 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 225 | $125.03 |
| 85384 | <1% | 98 | $116.18 | |
| 73552 | <1% | 17 | $115.68 | |
| 82947 | <1% | 33 | $115.58 | |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 40 | $110.18 |
| 76604 | <1% | 38 | $104.51 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 383 | $101.42 |
| 84295 | <1% | 341 | $101.01 | |
| 90714 | <1% | 16 | $96.66 | |
| 87400 | <1% | 492 | $83.71 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 165 | $81.88 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,177 | $81.71 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,274 | $77.12 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,319 | $76.37 |
| G0008 | Administration of influenza virus vaccine | <1% | 146 | $73.83 |
| 82044 | <1% | 228 | $72.53 | |
| 93288 | <1% | 13 | $71.52 | |
| 69210 | <1% | 16 | $69.00 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 877 | $67.50 |
| 92579 | <1% | 17 | $65.90 | |
| 86706 | <1% | 40 | $58.15 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | <1% | 416 | $51.55 |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 224 | $49.44 |
| 82962 | <1% | 53 | $44.40 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 623 | $43.96 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 156 | $43.24 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 203 | $42.23 |
| 87210 | <1% | 54 | $41.57 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 889 | $35.87 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 6,387 | $32.02 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 39 | $29.04 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 315 | $27.09 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,826 | $21.79 |
| 92555 | <1% | 12 | $21.78 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 192 | $17.60 |
| 87075 | <1% | 15 | $15.99 | |
| 85390 | <1% | 46 | $15.83 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 401 | $14.99 |
| 82374 | <1% | 243 | $7.32 | |
| 88720 | <1% | 20 | $7.00 | |
| 83550 | <1% | 60 | $6.56 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 51 | $5.62 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 466 | $5.46 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 60 | $2.69 |
| 90662 | <1% | 12 | $1.95 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 18 | $1.44 |
| 91300 | <1% | 147 | $1.42 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 599 | $0.33 |
| 88342 | 0% | 120 | $0.00 | |
| C1769 | Guide wire | 0% | 1,010 | $0.00 |
| 00790 | 0% | 29 | $0.00 | |
| 96368 | 0% | 19 | $0.00 | |
| 86580 | 0% | 16 | $0.00 | |
| 85576 | 0% | 44 | $0.00 | |
| 00126 | 0% | 12 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 129 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 0% | 14 | $0.00 |
| L8699 | Prosthetic implant, not otherwise specified | 0% | 22 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 15 | $0.00 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 464 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 40 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 846 | $0.00 |
| 85347 | 0% | 105 | $0.00 | |
| 82108 | 0% | 17 | $0.00 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 0% | 14 | $0.00 |
| 00811 | 0% | 40 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 16 | $0.00 |
| 90461 | 0% | 22 | $0.00 | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 0% | 14 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 18 | $0.00 |
| C1874 | Stent, coated/covered, with delivery system | 0% | 17 | $0.00 |
| 82010 | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBUIT, TIMOTHY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Lima Memorial Joint Operating Company | Lima, OH | $619K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.